% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

  • coldpizza22 coldpizza22 Apr 30, 2013 8:47 PM Flag

    From post on Investor Village NBIX board

    what the H is this?????????????

    comments that Endometriosis P3 Violet Petal is recruiting more patients??????

    if that is true than we won't see P3 top Line data untill late 2014
    The trial is 6 months of treatment 6 to 12 months of follow up.

    I really hope this gets clarified on Thursday or NBIX going to trade back to single digits.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • From todays Needham Presentation and their New corporate slides that are on thier Web site.

      So now NBIX management talking sometime in 2014 for top Line violet petal study read out vs the more anticipated 1H/14. So I would say Q4/14 is the best we are going to get and knowing this management team and their History of meeting dead lines think early 2015.

      The stock continues its slide this AM

45.060.00(0.00%)Oct 24 4:00 PMEDT